Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC

Completed

• Conditions: Adjuvant; Chemotherapy; Lung; Cancers

• Registration Number: NCT00484016
• Lead Sponsor: Washington University School of Medicine

Brief Summary

There are limited numbers of retrospective studies showing the effectiveness of adjuvant chemotherapy over observation in resected lung cancers.

Detailed Description

We propose to retrospectively examine the Washington University School of Medicine experience on all patients receiving adjuvant chemotherapy between 2003 and 2005. We will retrospectively analyze the survival and outcomes in the lung cancer patients receiving adjuvant chemotherapy following surgical resection.

Study Timeline

• Study Start: 2006-02
• Primary Completion: 2007-04
• Study Completion: 2007-04
• Study First Submitted: 2007-06-04
• Study First Submitted QC: 2007-06-06
• Study First Posted: 2007-06-08
• Status Verified: 2013-08
• Last Update Submitted: 2013-08-09
• Last Update Posted: 2013-08-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

• Patients that received adjuvant chemotherapy
• 18-88 years

Exclusion Criteria

• Any patients that have not received adjuvant chemotherapy
• Patients under 18 or over 88

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified